Showing results (21-30 of 1,289) with videos related to
Sort By:
Pageof 129
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|April 17, 2001
Coprinol, a new antibiotic cuparane from a Coprinus speciesM Johansson, O Sterner, H Labischinski, et al.The Japanese Journal of Antibiotics|June 30, 1998
[Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50]H Hanaki, H Labischinski, Y Inaba, et al.The Journal of Biological Chemistry|June 5, 1989
The tetrameric form of ribosomal protein L7/L12 from Escherichia coliY Georgalis, J Dijk, H Labischinski, et al.Journal of Bacteriology|January 1, 1997
Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureusA M Strandén, K Ehlert, H Labischinski, et al.Journal of Bacteriology|January 1, 1991
Direct proof of a "more-than-single-layered" peptidoglycan architecture of Escherichia coli W7: a neutron small-angle scattering studyH Labischinski, E W Goodell, A Goodell, et al.European Journal of Biochemistry|July 1, 1982
Infrared spectroscopy, a tool for probing bacterial peptidoglycan. Potentialities of infrared spectroscopy for cell wall analytical studies and rejection of models based on crystalline chitinD Naumann, G Barnickel, H Bradaczek, et al.European Journal of Biochemistry|October 15, 1984
A new proposal for the primary and secondary structure of the glycan moiety of pseudomurein. Conformational energy calculations on the glycan strands with talosaminuronic acid in 1C conformation and comparison with mureinB Leps, H Labischinski, G Barnickel, et al.Journal of Bacteriology|March 1, 1993
Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureusU Henze, T Sidow, J Wecke, et al.Antimicrobial Agents and Chemotherapy|September 3, 1999
Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureusH Komatsuzawa, K Ohta, H Labischinski, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 5, 2002
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureusR Geisel, F J Schmitz, A C Fluit, et al.Pageof 129